LON:TILS

Tiziana Life Sciences - TILS Share Forecast, Price & News

GBX 58.50

+4.50 (+8.33%)

(As of 10/20/2021)

Add

Compare

Today's Range: 45
▼
59
50-Day Range: 58.50
▼
58.50
52-Week Range: 30
▼
195

Volume: 297,127 shs
Average Volume: 522,223 shs
Market Capitalization: £113.85 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Tiziana Life Sciences (LON:TILS) Stock

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. The company also develops anti-IL6R (TZLS-501), a human anti-interleukin-6 receptor monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat COVID-19 patients with severe respiratory symptoms. It has a collaboration agreement with FHI Clinical Inc. to conduct a phase 2 clinical trial for treating hospitalized severe COVID-19 patients with intranasal foralumab, a human anti-CD3 monoclonal antibody. The company was incorporated in 1998 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.

Receive TILS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TILS Stock News Headlines

July 2, 2022 | proactiveinvestors.com

Tiziana Life Sciences' half-term report reveals it has made progress on all fronts

June 17, 2022 | finance.yahoo.com

Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice

June 9, 2022 | fool.co.uk

Tiziana Life Sciences

June 7, 2022 | investing.com

Advan Co Ltd (7463)

March 24, 2022 | proactiveinvestors.com

Tiziana Life Sciences: Multiple Sclerosis single study

March 24, 2022 | proactiveinvestors.com

Tiziana Life Sciences: Method of therapy delivery gives firm 'a novel market position'

January 28, 2022 | proactiveinvestors.com.au

2022 update: US listing and fresh data emerging

January 26, 2022 | lse.co.uk

MaxCyte expects improved full-year revenue on organic growth

October 28, 2021 | lse.co.uk

Tiziana Life Sciences Plc Share Chat

October 19, 2021 | finanznachrichten.de

Tiziana Life Sciences Plc: Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capital

October 19, 2021 | finance.yahoo.com

Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capital

September 24, 2021 | finance.yahoo.com

Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021

September 22, 2021 | proactiveinvestors.com

Tiziana Life Sciences: A different approach, tackling disease using a safe, nasal and oral antibody

September 7, 2021 | finance.yahoo.com

Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment

September 3, 2021 | finance.yahoo.com

Tiziana Life Sciences plc Posting of Scheme Document and Notice of Meetings

September 2, 2021 | finance.yahoo.com

TLSA: Foralumab Now in CAR T

August 21, 2021 | finanznachrichten.de

Tiziana Life Sciences Plc: Tiziana Life Sciences plc files scheme of arrangement to effect a corporate reorganisation

August 20, 2021 | benzinga.com

Tiziana Life Sciences plc files scheme of...

August 20, 2021 | proactiveinvestors.com

Tiziana Life Sciences set for Nasdaq move

August 17, 2021 | finance.yahoo.com

Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil

August 5, 2021 | proactiveinvestors.com.au

Tiziana Life Science - Second Price Monitoring Extn

August 5, 2021 | proactiveinvestors.com

Tiziana Life Science - Price Monitoring Extension

July 1, 2021 | finance.yahoo.com

TLSA: Intranasal Foralumab in COVID-19

June 30, 2021 | finance.yahoo.com

Dr Howard Weiner, Chairman of the Tiziana Scientific Advisory Board, to give an interview on Bloomberg Markets at 1.50pm ET today

June 25, 2021 | finance.yahoo.com

Tiziana Life Sciences plc (the "Company") Result of Annual General Meeting

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TILS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TILS Company Calendar

Last Earnings: 9/30/2020
Today: 8/12/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:TILS
Previous Symbol: LON:ADI
CUSIP: N/A
CIK: N/A
Web: www.tizianalifesciences.com
Phone: +44-20-74952379
Fax: N/A
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 2.36
Current Ratio: 6.54
Quick Ratio: 6.41

Sales & Book Value

Annual Sales: £-3,595,000.00
Price / Sales: -31.67
Cash Flow: GBX 25.70 per share
Price / Cash Flow: 2.28
Book Value: GBX 23.50 per share
Price / Book: 2.49

Miscellaneous

Outstanding Shares: 194,612,000
Free Float: N/A
Market Cap: £113.85 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Gabriele Marco Antonio Cerrone M.B.A. (Age 49)
MBA, Founder & Exec. Chairman
Comp: $13.76M
Dr. Kunwar Shailubhai (Age 63)
CEO, Chief Scientific Officer & Exec. Director
Comp: $810k
Dr. Andrea Brancale
Scientific Founder
Mr. Richard Clarkson Ph.D.
Scientific Founder
Mr. Andrew Westwell Ph.D.
Scientific Founder
Ms. Keeren Shah (Age 44)
Fin. Director
Dr. Thomas H. Adams (Age 78)
Head of Drug Devel. & Exec. Director
Dr. Neil Graham M.P.H. (Age 62)
MBBS, M.D., MPH, Chief Medical Officer
Dr. Napoleone Ferrara (Age 63)
Chairman of Scientific Advisory Board
Prof. Roberto Pellicciari
Consultant

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TILS Stock - Frequently Asked Questions

How have TILS shares performed in 2022?: Tiziana Life Sciences' stock was trading at GBX 58.50 at the beginning of the year. Since then, TILS shares have increased by 0.0% and is now trading at GBX 58.50.
View the best growth stocks for 2022 here.
How were Tiziana Life Sciences' earnings last quarter?: Tiziana Life Sciences PLC (LON:TILS) issued its quarterly earnings results on Wednesday, September, 30th. The biotechnology company reported ($2.60) EPS for the quarter, topping analysts' consensus estimates of ($4.00) by $1.40.
What other stocks do shareholders of Tiziana Life Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Synergy Pharmaceuticals (SGYP), Micron Technology (MU), ServiceNow (NOW), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Dropbox (DBX), Enterprise Products Partners (EPD) and Franco-Nevada (FNV).

What is Tiziana Life Sciences' stock symbol?: Tiziana Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "TILS."
How do I buy shares of Tiziana Life Sciences?: Shares of TILS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Tiziana Life Sciences' stock price today?: One share of TILS stock can currently be purchased for approximately GBX 58.50.
How much money does Tiziana Life Sciences make?: Tiziana Life Sciences (LON:TILS) has a market capitalization of £113.85 million and generates £-3,595,000.00 in revenue each year.
How can I contact Tiziana Life Sciences?: Tiziana Life Sciences' mailing address is 3rd Fl, 11-12 St. James's Square, LONDON, SW1Y 4LB, United Kingdom. The official website for the company is www.tizianalifesciences.com. The biotechnology company can be reached via phone at +44-20-74952379.

This page (LON:TILS) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Tiziana Life Sciences - TILS Share Forecast, Price & News

About Tiziana Life Sciences (LON:TILS) Stock

TILS Stock News Headlines

TILS Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

TILS Stock - Frequently Asked Questions

How have TILS shares performed in 2022?

How were Tiziana Life Sciences' earnings last quarter?

What other stocks do shareholders of Tiziana Life Sciences own?

What is Tiziana Life Sciences' stock symbol?

How do I buy shares of Tiziana Life Sciences?

What is Tiziana Life Sciences' stock price today?

How much money does Tiziana Life Sciences make?

How can I contact Tiziana Life Sciences?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources